A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes (NCT07668336)
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes
🩺 Plain-English Summary (8th-Grade Level)
This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them. Participation in the study will last about 61 weeks.
Who can join: Review the eligibility criteria below.
Location: Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology — Sacramento, California
Age range: 10 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (71 Sites)
Showing the first 25 of 71 sites.
- Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology — Sacramento, California
- Rady Children's Hospital — San Diego, California
- Stamford Therapeutics Consortium — Stamford, Connecticut
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics (CAP) — Atlanta, Georgia
- CenExel iResearch, LLC — Decatur, Georgia
- Medical Research Partners — Ammon, Idaho
- Cotton O'Neil Diabetes & Endocrinology — Topeka, Kansas
- SUNY Upstate Medical University — Syracuse, New York
- Advantage Clinical Trials — The Bronx, New York
- Central States Research — Tulsa, Oklahoma
- Frontier Clinical Research, LLC — Smithfield, Pennsylvania
- Vanderbilt Health One Hundred Oaks — Nashville, Tennessee
- Gadolin Research — Beaumont, Texas
- Driscoll Children's Hospital — Corpus Christi, Texas
- Proactive Clinical Research LLC — Edinburg, Texas
- Consano Clinical Research, LLC — Shavano Park, Texas
- Victoria Clinical Research Group — Victoria, Texas
- Cliniques universitaires Saint-Luc — Brussels,
- UZ Gent — Ghent,
- UZ Leuven — Leuven,
- Instituto de Pesquisa clinica de Campinas — Campinas,
- Centro de Pesquisa Sao Lucas — Campinas,
- Cendi - Endocrinologia e Diabetes — Goiânia,
- Instituto Méderi de Pesquisa e Saúde — Passo Fundo,
- Instituto da Crianca com Diabetes — Porto Alegre,
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus, Type 2
- Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA — Santa Barbara, California
- Diabetes Discharge Transitional CGM Study (DDT-CGM) — Logan, Utah
- Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM) — Birmingham, Alabama
- MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia — Las Vegas, Nevada
- Strategies to Improve Well-Being and Diabetes Management — Westbrook, Maine
- Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes — Montreal, Quebec
Explore by condition: All Diabetes Mellitus, Type 2 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.